Suicide by means of opioid overdose in patients with chronic pain

Parvaz Madadi1, Nav Persaud

  • 1Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5B 2J1, Canada, parvaz.madadi@gmail.com.

Insights

Opioid overdose deaths are increasing, with a focus on accidental fatalities. This study highlights the critical need to also address suicide by prescription opioid overdose, urging physicians to screen for suicide risk.

Area of Science:

  • Medical Research
  • Public Health
  • Pain Management

Background:

  • Prescription opioid use and associated deaths are a growing concern in North America.
  • Current prevention strategies primarily target non-intentional (accidental) opioid fatalities.
  • Suicide by opioid overdose represents a significant, yet often overlooked, cause of death.

Purpose of the Study:

  • To emphasize the importance of addressing suicide by prescription opioid overdose.
  • To advocate for the inclusion of suicide risk screening in opioid prescribing practices.
  • To highlight the need for optimizing chronic pain management in patients at risk for suicide.

Main Methods:

  • Review of existing literature on opioid-related deaths and suicide.
  • Analysis of current opioid prescribing guidelines and risk assessment tools.
  • Discussion of clinical considerations for physicians prescribing opioids.

Main Results:

  • The majority of opioid-related deaths are non-intentional, but suicide by overdose is a critical issue.
  • Existing opioid prescribing tools often neglect suicide risk assessment.
  • Chronic pain patients prescribed opioids may be at elevated risk for suicide.

Conclusions:

  • Physicians must consider suicide risk when prescribing opioids.
  • Integrating suicide screening into pain management is crucial for reducing opioid-related deaths.
  • Comprehensive strategies are needed to address both accidental and intentional opioid overdose fatalities.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...